Agilent InfinityLab LC Virtual Conference - Day 2

Welcome to the first Agilent InfinityLab LC Virtual Conference

This two-day interactive online conference offers you valuable information for keeping up-to-date on the latest LC trends and developments in the field.

During the two-day conference, you will have the opportunity to:

• Listen to top scientific leaders and application experts from the comfort of your home or office
• Ask each speaker questions in the real-time Q&A session following each broadcast
• Visit our exhibition booths virtually through the online platform
• Virtually meet, chat, and exchange ideas with all participants, as well as with Agilent experts

This first-of-its-kind virtual Agilent InfinityLab LC conference offers:

• An exciting meeting in a virtual environment, conducive to business, scientific and social exchange
• Access to both the fundamental and practical aspects of separation science, with the main focus on new and highly relevant trends emerging in this field
• The opportunity to focus on the newest scientific trends and professional developments in LC

This is a meeting for you – feel free to get involved, ask questions, make suggestions and be a part of the Agilent InfinityLab LC Community.

Register today and stay up-to-date on the scientific program.

Day 2 - 23 June 2021

09:00 - 09:05 (CEST) : Session: Trends in Biopharmaceutical Analysis Part 1

• Chair: Koen Sandra (RIC Group, Belgium)

09:05 - 09:30 (CEST) : Targeted Bottom-up Characterization of Recombinant Monoclonal Antibodies by Multidimensional LC/MS

• Cinzia Stella (Genentech, CA, USA)

09:30 - 09:55 (CEST) : 2D-LC in the pharmaceutical industry: from the characterization of complex drug modalities to high throughput analysis

• Alexandre Goyon (Genentech, USA)

09:55 - 10:20 (CEST) : Coupling non denaturing chromatographic techniques with mass spectrometry for biopharmaceuticals characterization

• Davy Guilarme (Geneva University, Switzerland)

10:20 - 10:50 (CEST) : Break

10:50 - 10:55 (CEST) : Session: Trends in Biopharmaceutical Analysis Part 2

• Chair: Koen Sandra (RIC Group, Belgium)

10:55 - 11.20 (CEST) : Exploring the chemical space of modifications in therapeutic proteins employing chromatography, mass spectrometry, and bioinformatics

• Christian Huber (University of Salzburg, Austria)

11:20 - 11:45 (CEST) : Bioanalysis of therapeutic proteins

• Rainer Bischoff (Univeristy of Groningen, The Netherlands)

11:45 - 12:10 (CEST) : Challenges in Analytical Characterization of Biosimilars

• Anurag Rathore (Indian Institute of Technology, India)

12:10 - 13:10 (CEST) : Break

13:10 - 13:15 (CEST) : Session: Innovations and novel insights in Liquid Chromatography Part 1

• Chair: Ken Broeckhoven (Vrije Universiteit Brussel, Belgium)

13:15 - 13:40 (CEST) : Rationalisation of peak shapes of peptides and mAbs in reversed-phase LC using a variety of mobile phase additives

• David McCalley (UWE Bristol, United Kingdom)

13:40 - 14:05 (CEST) : Comparison of HILIC and RP approach in the multiplex analysis of antivirals to tackle Drug-Drug Interactions

• Lucie Nováková (Charles University, Czech Republik)

14:05 - 14:30 (CEST) : Implementing Miniaturized Separation Platforms into Pharmaceutical Workflows

• James Grinias (Rowan University, USA)

14:30 - 15:00 (CEST) : Break

15:00 – 15:05 (CEST) : Session: Innovations and novel insights in Liquid Chromatography Part 2

• Chair: Ken Broeckhoven (Vrije Universiteit Brussel, Belgium)

15:05 – 15:30 (CEST) : Shedding light on mechanisms leading to convex-upward van Deemter curves on a cellulose tris (4-chloro-3-methylphenylcarbamate)-based chiral stationary phase

• Martina Catani (University of Ferrara, Italy)

15:30 – 15:55 (CEST) : Innovations in temperature responsive liquid chromatography

• Frederic Lynen (University of Gent, Belgium)

15:55 – 16:20 (CEST) : Design aspects of a microfluidic device for comprehensive spatial three-dimensional LC

• Sebastiaan Eeltink (Vrije Universiteit Brussel, Belgium)